{"version":"1.0","type":"link","title":"CTHRC1 is associated with (V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma.","author_name":"Zhang R 외","author_url":"https://prs-insight.online/author/Zhang%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/142279","thumbnail_width":1200,"thumbnail_height":630}